Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-29 @ 5:34 PM
Study NCT ID:
NCT04399395
Status:
WITHDRAWN
Last Update Posted:
2021-03-01
First Post:
2020-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery
Sponsor:
Oslo University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-19
First Submit QC Date:
None
Study First Post Date:
2020-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-25
Last Update Post Date:
2021-03-01
Last Update Post Date Type:
ACTUAL